Free Trial
→ Sell these 'safe' blue chips immediately (From Chaikin Analytics) (Ad)tc pixel Free KRON Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Kronos Bio (KRON) Short Interest Ratio & Short Volume

Kronos Bio logo
Compare

Kronos Bio Short Interest Overview

As of May 31, 2025, Kronos Bio (KRON) had a short interest of 754,300 shares sold short, representing 1.91% of the public float. This marks a 37.67% increase in short interest since the prior report. The short interest ratio (days to cover) is 1.0, meaning it would take 1.0 days of the average trading volume of 1.25 million shares to cover all short positions.

Current Short Interest
754,300 shares
Previous Short Interest
547,900 shares
Change Vs. Previous Month
37.67%
Dollar Volume Sold Short
$504.02 thousand
Short Interest Ratio
1.0 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
61,050,000 shares
Float Size
39,420,000 shares
Short Percent of Float
1.91%
Today's Trading Volume
54,089 shares
Average Trading Volume
1,246,986 shares
Today's Volume Vs. Average
4%
Short Selling Kronos Bio?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Kronos Bio and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

KRON Short Interest Over Time

KRON Days to Cover Over Time

KRON Percentage of Float Shorted Over Time

Kronos Bio Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/2025754,300 shares $504.02 thousand +37.7%1.9%1 $0.67
5/15/2025547,900 shares $386.27 thousand -18.4%1.4%1.1 $0.71
4/30/2025671,400 shares $599.43 thousand +0.3%1.7%1.9 $0.89
4/15/2025669,400 shares $581.04 thousand +9.5%1.7%4 $0.87
3/31/2025611,600 shares $504.57 thousand -18.2%1.6%3.3 $0.83
3/15/2025748,000 shares $703.12 thousand -13.4%1.9%3.2 $0.94
2/28/2025863,500 shares $846.23 thousand -5.9%2.2%3.3 $0.98
2/15/2025918,000 shares $936.36 thousand -2.1%2.4%3.1 $1.02
1/31/2025937,500 shares $946.88 thousand +63.1%2.4%3 $1.01
1/15/2025574,800 shares $563.30 thousand -0.5%1.5%2 $0.98
12/31/2024577,700 shares $548.82 thousand +16.5%1.5%2.3 $0.95
12/15/2024496,000 shares $486.03 thousand -1.1%1.3%2.6 $0.98
11/30/2024501,300 shares $476.24 thousand -3.8%1.3%2.8 $0.95
11/15/2024521,000 shares $442.85 thousand -1.3%1.4%4.5 $0.85
10/31/2024527,700 shares $511.87 thousand -21.8%1.3%6.4 $0.97
10/15/2024674,500 shares $647.52 thousand -5.6%1.7%7.7 $0.96
9/30/2024714,200 shares $714.13 thousand -4.6%1.8%5.9 $1.00
9/15/2024748,400 shares $710.98 thousand -1.3%1.9%4.9 $0.95
8/31/2024758,500 shares $796.43 thousand +7.7%1.9%2.5 $1.05
8/15/2024704,500 shares $695.76 thousand -2.0%1.8%2 $0.99
7/31/2024718,500 shares $934.05 thousand -7.8%1.9%1.9 $1.30
7/15/2024779,500 shares $1.12 million +8.2%2.0%1.5 $1.44
6/30/2024720,200 shares $893.05 thousand -0.5%1.9%1.4 $1.24
6/15/2024723,500 shares $781.38 thousand +5.0%1.9%1.5 $1.08
5/31/2024688,800 shares $544.15 thousand -3.5%1.6%1.6 $0.79
5/15/2024714,100 shares $700.82 thousand +4.0%1.7%1.6 $0.98
4/30/2024686,800 shares $707.40 thousand +3.6%1.7%1.7 $1.03
4/15/2024662,700 shares $755.48 thousand -0.4%1.7%1.9 $1.14
3/31/2024665,000 shares $864.50 thousand -0.4%1.7%2.6 $1.30
3/15/2024667,800 shares $774.65 thousand +11.2%1.7%2.7 $1.16
2/29/2024600,400 shares $624.42 thousand -1.8%1.6%2.3 $1.04
2/15/2024611,600 shares $660.53 thousand +2.3%1.6%4.1 $1.08
1/31/2024597,700 shares $675.40 thousand -74.9%1.6%2.9 $1.13
1/15/20242,380,000 shares $2.81 million -0.4%6.3%10.9 $1.18
12/31/20232,390,000 shares $2.99 million -1.7%6.3%8.8 $1.25
12/15/20232,430,000 shares $3.62 million -10.7%6.4%8.8 $1.49
11/30/20232,720,000 shares $3.24 million -0.4%7.2%10.5 $1.19
11/15/20232,730,000 shares $2.48 million +0.4%7.3%10.6 $0.91
10/31/20232,720,000 shares $2.38 million -1.8%7.0%14 $0.87
10/15/20232,770,000 shares $2.75 million -0.7%7.2%15 $0.99
This could be 100 times bigger than SpaceX’s rocket business (Ad)

A new SpaceX project was just disclosed on page 224 of an official SEC filing - and it could be worth 100 times more than SpaceX's rocket business. Chief Investment Officer Joel Litman recorded a video update live from West Texas, where this technology is coming online. He outlines a way to potentially profit from this venture without touching SpaceX's stock directly.tc pixel

Watch Joel Litman's video breakdown of this SpaceX opportunity now
9/30/20232,790,000 shares $3.63 million -2.1%7.2%18.4 $1.30
9/15/20232,850,000 shares $3.51 million +0.7%7.4%10.7 $1.23
8/31/20232,830,000 shares $3.93 million No Change7.4%10 $1.39
8/15/20232,830,000 shares $4.67 million -1.4%7.4%9.4 $1.65
7/31/20232,870,000 shares $5.51 million -0.7%7.6%9.1 $1.92
7/15/20232,890,000 shares $6.01 million -13.2%7.6%7.1 $2.08
6/30/20233,330,000 shares $5.73 million -21.5%8.7%7.9 $1.72
6/15/20234,240,000 shares $7.21 million +5.2%11.0%10.5 $1.70
5/31/20234,030,000 shares $6.73 million +0.8%10.5%12.7 $1.67
5/15/20234,000,000 shares $7.48 million -5.0%10.4%12.6 $1.87
4/30/20234,210,000 shares $6.95 million -1.9%11.0%13.1 $1.65
4/15/20234,290,000 shares $5.58 million +3.6%11.2%14 $1.30
3/31/20234,140,000 shares $6.04 million +10.4%10.9%13.9 $1.46
3/15/20233,750,000 shares $5.63 million +7.5%9.9%12.3 $1.50
2/28/20233,490,000 shares $6.07 million +0.6%9.3%11.5 $1.74
2/15/20233,470,000 shares $7.25 million +1.2%9.3%11.6 $2.09
1/31/20233,430,000 shares $8.23 million -3.7%9.0%12 $2.40
1/15/20233,560,000 shares $9.33 million -0.3%9.4%13.6 $2.62
12/30/20223,570,000 shares $5.78 million -0.8%9.4%15.5 $1.62
12/15/20223,600,000 shares $6.66 million +1.7%9.5%18.7 $1.85
11/30/20223,540,000 shares $6.73 million -2.2%9.3%20.9 $1.90
11/15/20223,620,000 shares $8.65 million -1.4%9.5%20.3 $2.39
10/31/20223,670,000 shares $10.86 million No Change9.3%19.8 $2.96
10/15/20223,670,000 shares $10.42 million -0.3%9.3%17.1 $2.84
9/30/20223,680,000 shares $12.33 million +0.6%9.4%16.2 $3.35
9/15/20223,660,000 shares $17.53 million +3.7%9.3%14.1 $4.79
8/31/20223,530,000 shares $14.12 million +4.1%9.0%10.2 $4.00
8/15/20223,390,000 shares $17.49 million -3.7%8.6%8.3 $5.16
7/31/20223,520,000 shares $14.78 million -9.0%9.0%6.9 $4.20
7/15/20223,870,000 shares $19.12 million -3.7%9.8%7.5 $4.94
6/30/20224,020,000 shares $14.63 million -14.5%10.2%7.7 $3.64
6/15/20224,700,000 shares $15.75 million +2.2%11.9%9 $3.35
5/31/20224,600,000 shares $17.11 million +4.3%11.7%10.4 $3.72
5/15/20224,410,000 shares $17.24 million +2.8%11.0%11.3 $3.91
4/30/20224,290,000 shares $20.29 million +2.4%12.0%13.2 $4.73
4/15/20224,190,000 shares $24.68 million -3.5%11.7%13.8 $5.89
3/31/20224,340,000 shares $31.38 million -5.7%12.2%14.3 $7.23
3/15/20224,600,000 shares $32.84 million -0.9%12.9%15.2 $7.14
2/28/20224,640,000 shares $34.94 million +6.2%13.0%14.1 $7.53
2/15/20224,370,000 shares $30.94 million -6.4%12.1%12.5 $7.08
1/31/20224,670,000 shares $42.50 million -2.3%12.9%15.5 $9.10
1/15/20224,780,000 shares $51.05 million -11.3%13.2%17.3 $10.68
12/31/20215,390,000 shares $73.25 million +2.9%14.9%20.4 $13.59
12/15/20215,240,000 shares $70.79 million +3.8%14.5%19.6 $13.51
11/30/20215,050,000 shares $59.64 million +3.9%13.9%22.5 $11.81
11/15/20214,860,000 shares $81.41 million +10.7%13.4%22.4 $16.75
10/29/20214,390,000 shares $72.26 million +1.6%12.1%21.9 $16.46
10/15/20214,320,000 shares $72.49 million +0.2%11.9%22.9 $16.78
9/30/20214,310,000 shares $90.34 million +5.4%11.9%22.3 $20.96
9/15/20214,090,000 shares $98.08 million -2.2%11.3%16 $23.98
This is the worst news for stocks in 50 years (Ad)

Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst environment in 50 years - with portfolios potentially staying in the red for 10 years or longer. From rate spikes in 2022 to $12 trillion wiped out in 30 days during the Iran War, Wall Street suggests the volatility isn't slowing down. TradeSmith CEO Keith Kaplan is showing investors what steps to take now to prepare their wealth before this worsens.tc pixel

Click here to learn how to defend your portfolio before this hits
8/31/20214,180,000 shares $87.40 million -5.0%11.5%15 $20.91
8/13/20214,400,000 shares $88.44 million No Change12.1%15.4 $20.10
7/30/20214,400,000 shares $89.98 million -9.7%12.2%15.1 $20.45
7/15/20214,870,000 shares $99.45 million -2.6%13.5%16.4 $20.42
6/30/20215,000,000 shares $119.75 million +12.6%13.9%16.6 $23.95

KRON Short Interest - Frequently Asked Questions

Short interest is the volume of Kronos Bio shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 754,300 shares of KRON short. 1.91% of Kronos Bio's shares are currently sold short. Learn More on Kronos Bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRON shares currently have a short interest ratio of 1.0. Learn More on Kronos Bio's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.91% of Kronos Bio's floating shares are currently sold short.

Kronos Bio saw a increase in short interest in May. As of May 31st, there was short interest totaling 754,300 shares, an increase of 37.7% from the previous total of 547,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Kronos Bio currently has issued a total of 61,050,000 shares. Some of Kronos Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kronos Bio currently has a public float of 39,420,000 shares.

1.91% of Kronos Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kronos Bio: Lifecore Biomedical, Inc. (9.32%), Protara Therapeutics, Inc. (11.34%), Sagimet Biosciences Inc. (17.28%), Unicycive Therapeutics, Inc. (11.90%), Coherus Oncology, Inc. (19.66%), Sol-Gel Technologies Ltd. (5.64%), Karyopharm Therapeutics Inc. (24.00%), LENZ Therapeutics, Inc. (35.59%), Hillstream Biopharma Inc. (4.85%), Aurora Cannabis Inc. (11.99%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Inc ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling KRON is an investing strategy that aims to generate trading profit from Kronos Bio as its price is falling. KRON shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Kronos Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KRON, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRON, twice per month. The most recent reporting period available is May, 31 2025.

Understanding short interest metrics can help you assess how traders are positioning around a stock like KRON:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:KRON) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
A 3M Oz. Historical Gold Resource And A Market That Hasn't Caught Up
One Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a d...
Wall Street Logic | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel